FIELD: medicine.
SUBSTANCE: invention concerns pharmacology, veterinary science and medicine and covers a cytostatic composition containing coordination compounds of platinum, ascorbic acid and phenanthroline derivatives where as coordination compound of platinum, it contains cisplatin, as ascorbic acid and phenanthroline derivatives - ascorbate phenanthrolinate complex of platinum of formula [PtPhen2]Asc and ascorbate phenanthrolinate complex of europium of formula EuAscNO3Phen·4·H2O at the following mass ratio: cisplatin - 1; ascorbate phenanthrolinate complex of platinum - 2; ascorbate phenanthrolinate complex of europium - 3.
EFFECT: composition with antioxidant activity.
1 cl, 1 dwg, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR ANTIBLASTIC THERAPY | 2001 |
|
RU2192861C1 |
BIS-IMIDAZOLE-(1,10)-PHENANTHROLINE COPPER (II) DICHLORIDE SHOWING ANTIBACTERIAL AND ANTIBLASTIC ACTIVITY, METHOD OF ITS SYNTHESIS | 2001 |
|
RU2190616C1 |
IMMUNOSTIMULATING AND ANTIOXIDANT COMPOSITION | 2008 |
|
RU2372081C1 |
ANTIOXIDANT COMPOSITION (VERSIONS) | 2015 |
|
RU2593587C1 |
ANTIOXIDANT AND IMMUNOSTIMULATING COMPOSITION | 2010 |
|
RU2444358C1 |
IMMUNOSUPPRESSANT | 2011 |
|
RU2448696C1 |
BISIMIDAZOLE-(1,10)-PHENENTHROLINE PLATINUM (III) DICHLORIDE SHOWING CYTOSTATIC ANTITUMOR ACTIVITY | 1995 |
|
RU2089555C1 |
APOPTOSIN AND ANTIOXIDANT COMPOSITION | 2017 |
|
RU2682644C2 |
AGENT HAVING CYTOSTATIC AND APOPTOSIS-INDUCING ACTIVITY | 2005 |
|
RU2296578C2 |
ANTITUMOR, ANTIBACTERIAL AND ANTIVIRAL PHARMACEUTICAL COMPOSITION (ITS VARIANTS) | 2006 |
|
RU2319491C1 |
Authors
Dates
2009-12-10—Published
2008-09-15—Filed